A1 Refereed original research article in a scientific journal
Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling study
Authors: Johannesen, Caroline Klint; Gideonse, David; Osei-Yeboah, Richard; Lehtonen, Toni; Jollivet, Ombeline; Cohen, Rachel A.; Urchueguia-Fornes, Arantxa; Herrero-Silvestre, Maria; Lopez-Lacort, Monica; Kramer, Rolf; Fischer, Thea K.; Heikkinen, Terho; Nair, Harish; Campbell, Harry; van Boven, Michiel; PROMISE investigators
Publisher: Elsevier BV
Publishing place: AMSTERDAM
Publication year: 2025
Journal: Lancet regional health - Europe
Journal name in source: The Lancet Regional Health - Europe
Journal acronym: LANCET REG HEALTH-EU
Article number: 101227
Volume: 51
Number of pages: 13
ISSN: 2666-7762
DOI: https://doi.org/10.1016/j.lanepe.2025.101227(external)
Web address : https://doi.org/10.1016/j.lanepe.2025.101227(external)
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/491220454(external)
Background: Respiratory syncytial virus (RSV) can cause severe disease, notably among infants, older adults, and individuals with comorbidities. Non-systematic testing and differences in coding practices affect direct measures of the hospital disease burden. We aim to tackle this issue and estimate RSV-associated respiratory hospital admissions through time series modelling of hospital admissions.
Methods: The number of RSV hospital admissions in Denmark, England, Finland, the Netherlands, and Spain were estimated with attribution analyses, using age-specific respiratory tract infection (RTI) admissions combined with virological data, both from routinely collected healthcare data. Analyses covered the years 2016-2023.
Findings: The attributed incidence of RSV per 100,000 children 0-2 months ranged from 1715 in Denmark to 3842 in England. In older adults, substantial differences in the incidence of ICD-10 coded RSV hospitalisations were found, while the attributed RSV incidence was more comparable, ranging from approximately 100 per 100,000 in adults 65-74 years to 200 per 100,000 persons 75-84 years and 500 per 100,000 persons 85 years and older.
Interpretation: RSV-attributed time series exhibit a high degree of synchronicity between participating countries, suggesting that this method for attribution addresses the known issues with underdiagnosis and misclassification. In the older age groups, a substantial proportion of RTI hospitalisations is attributed to RSV, underscoring the relevance of RSV as a cause of severe respiratory infections.
Downloadable publication This is an electronic reprint of the original article. |
Funding information in the publication:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement 101034339. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA.